Nanospectra Biosciences

About:

Nanospectra Biosciences develops particle-based therapies for the selective and precise thermal destruction of solid tumors.

Website: http://www.nanospectra.com

Top Investors: Sirtex Medical

Description:

Nanospectra Biosciences is a medical device company, engages in developing and commercializing particle-based therapies for the selective and precise thermal destruction of solid tumors. The company provides AuroLase Therapy, a medical device that is applicable to the ablation of various solid tumors. It also offers research-use-only nanoparticles with specific optical characteristics. Nanospectra Biosciences was founded in 2002 and is based in Houston, Texas.

Total Funding Amount:

$16.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Houston, Texas, United States

Founded Date:

2002-01-01

Contact Email:

info(AT)nanospectra.com

Founders:

Jennifer West, Naomi Halas

Number of Employees:

1-10

Last Funding Date:

2023-03-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai